Royalty Pharma plc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Royalty Pharma plc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Royalty Pharma plc - Ordinary Shares - Class A
Rating: 2.507444375
Author: Trendlyne DVM scores

Turnaround Potential

about

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

39.25 0.09 (0.23%)

Near 52W High of $41.24

387.7K

XNAS Volume

XNAS 18 Nov, 2025 10:19 AM (EST)

Medium Financial Strength

44.4 / 100

Mid Valuation

44.7 / 100

Technically Moderately Bullish

67.0 / 100

Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM

1Yr Price target upside is 16%

9 analysts

Royalty Pharma plc Ordinary Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Royalty Pharma plc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

Near 52W High of $41.24

SWOT Analysis

Royalty Pharma plc Ordinary Live Price Chart